Glen Eagle Advisors, LLC Embecta Corp. Transaction History
Glen Eagle Advisors, LLC
- $604 Billion
- Q1 2025
A detailed history of Glen Eagle Advisors, LLC transactions in Embecta Corp. stock. As of the latest transaction made, Glen Eagle Advisors, LLC holds 175 shares of EMBC stock, worth $1,849. This represents 0.0% of its overall portfolio holdings.
Number of Shares
175
Previous 175
-0.0%
Holding current value
$1,849
Previous $3.61 Million
38.27%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding EMBC
# of Institutions
415Shares Held
56.3MCall Options Held
54.8KPut Options Held
32.3K-
Black Rock Inc. New York, NY9.19MShares$97.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.74MShares$71.2 Million0.0% of portfolio
-
American Century Companies Inc Kansas City, MO3.81MShares$40.3 Million0.03% of portfolio
-
River Road Asset Management, LLC3.23MShares$34.1 Million0.58% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY2.72MShares$28.8 Million0.88% of portfolio
About Embecta Corp.
- Ticker EMBC
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 57,836,500
- Market Cap $611M
- Description
- Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...